The effect of magnesium sulfate with ketorolac and morphine with ketorolac on relief pain

Comparison of the effect of magnesium sulfate with ketorolac and morphine with ketorolac on pain in patients with colic

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20160130026253N4

Enrollment

Registered

2020-05-20

Start date

2020-06-21

Completion date

Unknown

Last updated

2020-06-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Renal colic. Renal colic

Interventions

Intervention 1: Patients with renal colic in this group will be received magnesium sulfate at a dose of 30 mg/kg and ketorolac at a dose of 30 mg in a volume of 100 cc at 15 minutes. Intervention 2: I

Eligibility

Sex/Gender

All

Age

17 Years to No maximum

Inclusion criteria

Inclusion criteria: Clinical diagnosis of renal colic Satisfaction of patients or their companions to enter the study

Exclusion criteria

Exclusion criteria: Allergy to morphine or ketorolac Renal dysfunction injection of analgesic in the past 60 hours bleeding diseases Use of warfarin Drug addiction Pregnancy and breastfeeding

Design outcomes

Primary

Measure	Time frame
Pain Score. Timepoint: 20, 40, 60 minutes after drug administration. Method of measurement: Visual Analogue Scale (VAS).	—

Secondary

Measure	Time frame
Side effects. Timepoint: 60 minutes after drug administration. Method of measurement: Observation.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAlireza Abootalebi

Esfahan University of Medical Sciences

a_abootalebi@med.mui.ac.ir+98 31 3620 2085

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026